News

Biotech Firm Confirms 100% Accuracy of COVID-19 Mutation Assays

June 3, 2021 (Investorideas.com Newswire) Applied DNA Sciences’ SARS-CoV-2 mutation panel and its validation are discussed in a ROTH Capital Partners report.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News